Objective:

To map the global research landscape of non-pharmacological Traditional Chinese Medicine (TCM) therapies for supportive care in breast cancer, focusing on productivity, collaboration, and evolving research priorities.

Approach:

Key Findings:

• 1,761 documents were included, showing rapid growth in publications, especially after the mid-2010s.
• The US leads in output and collaboration, while China exhibits fast growth but limited international linkage.
• Research focus has shifted from treatment side-effect management to broader survivorship outcomes and evidence synthesis.

Interpretation:

The study highlights a significant increase in research on non-pharmacological TCM therapies for breast cancer, indicating a shift towards integrative supportive care.

Limitations:

• The study is limited to English-language publications, which may exclude relevant research in other languages.
• The bibliometric approach may not capture all nuances of clinical practice and patient experiences.

Conclusion:

Research on non-pharmacological TCM therapies for breast cancer is rapidly evolving, with a need for stronger international collaboration and standardized outcomes.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.